Artritis psoriásica: La elección del fármaco antirreumático biológico en la Ley Ricarte Soto / Choosing biological agents for the treatment of psoriatic arthritis
Rev. méd. Chile
;
148(5): 657-664, mayo 2020. tab
Artigo
em Espanhol
| LILACS
| ID: biblio-1139350
ABSTRACT
The financial coverage granted by law in Chile for patients with psoriatic arthritis who require biological treatment is of paramount importance and a great advance. However physicians must be knowledgeable about the advantages and limitations of this therapy. The challenge of clinicians is to choose the drug with the greater odds of achieving therapeutic success, with less adverse events and lower costs for our health system. This article aims to help doctors to select the best biological treatment for a specific patient, trying to optimize its effectiveness, minimizing adverse effects, always looking for an efficient use of resources.
Texto completo:
DisponíveL
Índice:
LILACS (Américas)
Assunto principal:
Médicos
/
Fatores Biológicos
/
Artrite Psoriásica
/
Tomada de Decisão Clínica
Tipo de estudo:
Estudo prognóstico
Limite:
Humanos
País/Região como assunto:
América do Sul
/
Chile
Idioma:
Espanhol
Revista:
Rev. méd. Chile
Assunto da revista:
Medicina
Ano de publicação:
2020
Tipo de documento:
Artigo
País de afiliação:
Chile
Instituição/País de afiliação:
Universidad del Desarrollo/CL
Similares
MEDLINE
...
LILACS
LIS